Uterine / Endometrial

To find out more about eligibility criteria, click on the ClinicalTrials.gov links and if you are interested in participating, email the coordinator by clicking on the envelope next to the coordinator's name and notify the coordinator. 

 

Treatment stage
Short name
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?

 Recurrent

STRO 002

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

NCT03748186

Christine Yang 

Eligibility Criteria 

Newly diagnosed

NRG-GY020

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

NCT04214067

Schuyler Nissen

Eligibility Criteria 

 Recurrent

COMET

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

NCT03617679

Schuyler Nissen

Eligibility Criteria